Track the Diagnostyka S.A. stock price and the full management transaction log of the company, a listed issuer based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, Diagnostyka S.A. has recorded 3 reports. Market capitalisation: €5.7bn. The latest transaction was disclosed on 18 May 2026 (Notification PDMR). The full history is free.
Analysts rate Diagnostyka S.A. Buy (bullish), based on 6 analysts. Average price target: PLN 197.45.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Diagnostyka S.A. es una empresa especializada en el sector de la salud y farmacéutico, que ofrece servicios de diagnóstico médico. Cotiza en el mercado XWAR.